Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis

다국어 초록 (Multilingual Abstract)

Background and Purpose Responses to repetitive nerve stimulation (RNS) in patients with muscle-specific tyrosine kinase (MuSK) antibody (Ab)-positive myasthenia gravis (MG) vary depending on the muscles tested. We analyzed the RNS responses of limb and facial muscles in MuSK-Ab-positive and acetylcholine receptor (AChR)-Ab-negative MG (MuSK MG) and MuSK-Ab-negative and AChR-Ab-negative [double-seronegative (DSN)] MG patients.
Methods We retrospectively compared RNS responses between 45 MuSK MG and 29 DSN MG. RNS was applied to the abductor digiti minimi, flexor carpi ulnaris, trapezius, orbicularis oculi, and nasalis muscles.
Results Abnormal RNS responses in limb muscles were observed in 22.2 and 58.6% of MuSK MG and DSN MG patients, respectively, with abnormal facial responses observed in 77.8 and 65.5%, and abnormal responses observed in any of the five muscles in 86.7 and 72.4%. Abnormal RNS responses in the abductor digiti minimi or flexor carpi ulnaris were less frequent in MuSK MG (8.9 and 15.6%, respectively) than in DSN MG (37.9 and 55.2%), whereas the findings for other muscles were not significantly different between the groups. Abnormal facial responses but normal limb responses were independently associated with MuSK MG (odds ratio=5.224, 95% confidence interval=1.300–20.990).
Conclusions Abnormal RNS responses primarily in facial muscles without involvement of limb muscles were more pronounced in MuSK MG than in DSN MG. RNS of both facial and limb muscles in AChR-Ab-negative MG can increase the test sensitivity and aid in early suspicion of MuSK MG.

참고문헌 (Reference)

• 1 Lavrnic D, "The features of myasthenia gravis with autoantibodies to MuSK" 76 : 1099-1102, 2005
• 2 김승민, "The Epidemiology of Myasthenia Gravis in Korea" 연세대학교의과대학 57 (57): 419-425, 2016
• 3 Padua L, "Seronegative myasthenia gravis: comparison of neurophysiological picture in MuSK+ and MuSK- patients" 13 : 273-276, 2006
• 4 Evoli A, "Response to therapy in myasthenia gravis with anti-MuSK antibodies" 1132 : 76-83, 2008
• 5 Oh SJ, "Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis" 33 : 500-504, 2006
• 6 Gilhus NE, "Myasthenia gravis" 375 : 2570-2581, 2016
• 7 오신중, "Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current Status" 대한신경과학회 5 (5): 53-64, 2009
• 8 Stickler DE, "MuSK-antibody positive myasthenia gravis: clinical and electrodiagnostic patterns" 116 : 2065-2068, 2005
• 9 Nikolic A, "Electrophysiological profile of the patients with MuSK positive myasthenia gravis" 36 : 945-949, 2014
• 10 Oh SJ, "Electrophysiological and clinical correlation in myasthenia gravis" 12 : 348-354, 1982
• 11 Wolfe GI, "Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis" 1132 : 71-75, 2008
• 12 Pasnoor M, "Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience" 41 : 370-374, 2010
• 13 Evoli A, "Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis" 126 (126): 2304-2311, 2003
• 14 Sanders DB, "Clinical aspects of MuSK antibody positive seronegative MG" 60 : 1978-1980, 2003
• 15 Hoch W, "Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies" 7 : 365-368, 2001
• 16 Guptill JT, "Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts" 44 : 36-40, 2011